José
Martínez Lanao
Catedrático de Universidad
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (19)
2021
-
Evaluation of current amikacin dosing recommendations and development of an interactive nomogram: The role of albumin
Pharmaceutics, Vol. 13, Núm. 2, pp. 1-13
2020
-
Amikacin initial dosage in patients with hypoalbuminaemia: an interactive tool based on a population pharmacokinetic approach
The Journal of antimicrobial chemotherapy, Vol. 75, Núm. 8, pp. 2222-2231
2019
-
Evaluation of renal function equations to predict amikacin clearance
Expert Review of Clinical Pharmacology, Vol. 12, Núm. 8, pp. 805-813
2017
-
Pharmacokinetics and dosing requirements of digoxin in pregnant women treated for fetal supraventricular tachycardia
Expert Review of Clinical Pharmacology, Vol. 10, Núm. 8, pp. 911-917
2009
-
Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients
Journal of Pharmacy and Pharmacology, Vol. 61, Núm. 6, pp. 759-766
2008
-
Recomendaciones para la monitorización de antibióticos en pacientes críticos ingresados en UCI
Enfermedades Infecciosas y Microbiologia Clinica
-
Recommendations for antibiotic monitoring in ICU patients
Farmacia Hospitalaria
2005
-
Time-dependent pharmacokinetics of cyclosporine (Neoral®) in de novo renal transplant patients
Journal of Clinical Pharmacy and Therapeutics, Vol. 30, Núm. 6, pp. 549-557
2004
-
Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates
Journal of Antimicrobial Chemotherapy, Vol. 54, Núm. 1, pp. 193-198
2003
-
Pharmacokinetic study of the digoxin-acenocoumarol interaction in rabbits
Biological and Pharmaceutical Bulletin, Vol. 26, Núm. 6, pp. 813-817
1999
-
Population pharmacokinetics of amikacin in patients with haematological malignancies
Journal of Antimicrobial Chemotherapy, Vol. 44, Núm. 2, pp. 235-242
1998
-
Influence of clinical diagnosis in the population pharmacokinetics of amikacin in intensive care unit patients
Clinical Drug Investigation, Vol. 15, Núm. 5, pp. 435-444
1996
-
Bayesian forecasting in paediatric populations
Clinical Pharmacokinetics
-
Influence of pharmacokinetic model on vancomycin peak concentration targets
Therapeutic Drug Monitoring, Vol. 18, Núm. 2, pp. 145-148
-
Pharmacokinetics of amikacin in intensive care unit patients
Journal of Clinical Pharmacy and Therapeutics, Vol. 21, Núm. 6, pp. 417-421
1993
-
Digoxin pharmacokinetics in patients with high serum digoxin concentrations
Journal of Clinical Pharmacy and Therapeutics, Vol. 18, Núm. 1, pp. 63-68
1989
-
Biological and kinetic behavior of aluminium overload in chronic renal failure during desferrioxamine administration
Nefrologia, Vol. 9, Núm. 1, pp. 72-77
1985
-
Urinary kinetics of triiodothyronine and their modification with aging
Hormone and Metabolic Research, Vol. 17, Núm. 7, pp. 366-369
1983
-
Serum lidocaine levels in patients undergoing fibrobronchoscopy
Therapeutic Drug Monitoring, Vol. 5, Núm. 2, pp. 201-203